Mehdi Salar Amoli; Sarah Rezapourdamanab; Linqi Jin; Melissa A. Cadena; Kaveeta Kaw; Vani Sridhar; Mostafa Meselhe; Sarah Krikor; Morteza Mahmoudi; Liqun Ning; Jenny Shim; Martin L. Tomov; Kelly C. Goldsmith; Vahid Serpooshan
STAR Protocols, Volume 6, Issue 2, 2025, 103725, ISSN 2666-1667, 20 June 2025
https://doi.org/10.1016/j.xpro.2025.103725
6 citations · 6 en 2025–2026
Les titres, résumés et légendes des publications sont présentés en anglais.
Abstract
Summary:
Here, we present a protocol for developing an in vitro 3D model of neuroblastoma through bioprinting, incorporating key components of the tumor microenvironment (TME), including vasculature and cancer cell line spheroids. We describe steps for the preparation, bioprinting, and evaluation of tumor models and their use to assess the impact of TME on solid tumor behavior. We report procedures for bioink preparation, bioprinting, the measurement of mechanical properties and fidelity, as well as the viability of different cell types and their interactions.
Keywords:
Cell culture; cancer; biotechnology and bioengineering.
Utilisation des équipements
Le protocole prévoit un Mach-1 muni d’un indenteur sphérique pour caractériser le modèle de neuroblastome bio-imprimé.
Matériaux (1)

Matériau
Hydrogel
Configurations de test (4)
Configuration de test
Cartographie 3D en indentation normale
Configuration de test
Compression Non-Confinée
Configuration de test
Indentation (Raideur)
Configuration de test